FLUDARABINE-BELMED

Fludarabine

Composition: each ampoule contains:

active substance: fludarabine phosphate – 50 mg.

Therapeutic indications

B-cell chronic lymphocytic leukemia (CLL) in patients with sufficient bone marrow reserve. The therapy with the drug product as the essential one should be administered in patients with progressing disease of Rai stage III/IV (Binet C) or Rai stage I/II (Binet A/B) when the patient has the symptoms connected with the disease or attribute of progressing disease.

	АТС code
	L01BB05
	Pharmaceutical form
	lyophilized powder for solution for injection 50 mg
	Storage conditions
	Store in protected from light place at temperature between 2°C and 8°C.